SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Alexion Pharmaceuticals, Inc. (ALXN)
An SI Board Since October 1997
Posts SubjectMarks Bans Symbol
824 29 0 ALXN
Emcee:  Larry Liebman Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
699>>Why does CNN think this is a stor>> Beats me. Maybe they felt thaIcebrg-11/14/2006
698Strange. Why does CNN think this is a story? keokalani'nui-11/14/2006
697Controversy surrounds failed test drug results Independent researcher faces off Icebrg-11/14/2006
696Pex news is being used to drive the stock down. Pretty funny since we were alreIRWIN JAMES FRANKEL-11/14/2006
695Alexion drug failed to boost heart attack survival Tue Nov 14, 2006 9:04am ET Ckenhott-11/14/2006
694Just a guess but FDA will get this one done fast, call it approval in January. IRWIN JAMES FRANKEL-11/14/2006
693Thanks Peter. You are right that we only see the one side and there could be otIRWIN JAMES FRANKEL-11/14/2006
692FDA Grants Priority Review for Soliris(TM) (eculizumab) BLA for Treatment of ParIcebrg-11/14/2006
691<i>reduction in IV says to me that this is a bullish position taken, ie itBiomaven-11/13/2006
690ALXN May07 50 put are active with 1290 contracts trading vs. open interest of 30IRWIN JAMES FRANKEL-11/13/2006
689Not bad for an indication that was discovered more or less by chance (some wouldIcebrg-11/10/2006
688[123] The Terminal Complement Inhibitor Eculizumab Reduces Thrombosis in Patientkenhott-11/10/2006
687Alexion Pharmaceuticals Up on Drug Data Friday November 10, 12:17 pm ET Alexion kenhott-11/10/2006
686NEW YORK, November 7 (newratings.com) - Analyst M Aberman of Credit Suisse initiIcebrg-11/7/2006
685Human C5aR knock-in mice facilitate the production and assessment of anti-inflamnigel bates-11/6/2006
684Credit Suisse initiates coverage on Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN)Icebrg-11/6/2006
683SI increased to 4.7M from 4.1MIRWIN JAMES FRANKEL-10/24/2006
682No, nothing sinister in my comment. Just saying be careful about taking $1 and kenhott-10/16/2006
681Why? Think it is going to soar? :-) I added in the low 30's and am comforIRWIN JAMES FRANKEL-10/13/2006
680IMO the danger of writing covered calls is doing a NBIX. You're not warningkeokalani'nui-10/13/2006
679Be careful about selling covered calls.kenhott-10/13/2006
678Citadel LP Raises Stake in Alexion Pharmaceuticals (ALXN) to 5% 10-12-2006 01:50Icebrg-10/13/2006
677A filing that gives the value of something OTHER than the security owned is uselIRWIN JAMES FRANKEL-10/11/2006
676I can't figure that filing out. A distressed, liquidating hedge fund...Ikeokalani'nui-10/11/2006
675Yep. Closer to $17M, $16,990,000 and that is represented as the "value&quoIRWIN JAMES FRANKEL-10/11/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News